Investigation of mutations in the TERT gene for cancer diagnosis
NewsAt The MCSC Center For Personalized Medicine, You can undergo a study for the presence of mutations in the TERT gene.These changes occur with high frequency in a number of malignant neoplasms (ZNO), including glial tumors, urothelial carcinoma, melanoma, and thyroid ZNO.
- The researchers found that TERT mutations were detected in 44% of cases of malignant tumors of the thyroid gland.
Analysis of the data showed that they can serve as markers of tumors of the endocrine organs, which can sometimes recur and at the same time be insensitive to radioiodine therapy.
- What is the purpose of the TERT gene mutation study?
Allows you to assess the predisposition to cancer in order to diagnose and treat them in a timely manner.
- Determines the sensitivity to the use of combined targeted therapy for skin melanoma, lung and thyroid cancer.
Who is recommended to perform a TERT gene study?To all patients with malignant neoplasms of the thyroid gland, glial tumors, urothelial carcinoma and melanomas for the choice of individual treatment tactics.
- In addition, the detection of this mutation during biopsy can significantly improve the diagnosis of cancer before surgery, as well as clarify the risk of recurrence of the disease after treatment.
- You will be able to get the result within 7 business days.Testing is carried out as part of paid medical services.
Make an appointment by phone: 8 (495) 305-05-50.
